IP Library Granted Patent US 7,304,208
Granted Patent B2
US 7,304,208 · App. 10/411,395 · Granted Dec 4, 2007

Expression of human serum albumin (HSA) in monocot seeds

Assignee: Ventria Bioscience
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,304,208
App. No.
10/411,395
Granted
Dec 4, 2007
Kind
B2
Abstract

A method of producing human serum albumin (HSA) in monocot plant seeds, by transforming a monocot plant cell with a chimeric gene containing a promoter from the gene of a maturation-specific monocot plant storage protein, a first DNA sequence operably linked to the promoter and encoding a signal sequence, and a second DNA sequence linked in translation frame with the first DNA sequence and encoding HSA, where the first DNA sequence and the second DNA sequence together encode a fusion protein containing an N-terminal signal sequence and the HSA; growing a monocot plant from the transformed monocot plant cell for a time sufficient to produce seeds containing the HSA; and harvesting the seeds from the plant.

Claims (9)

1. A method of producing human serum albumin (HSA) in monocot plant seeds, comprising the steps of:

(a) transforming a monocot plant cell with a chimeric gene comprising

(i) a promoter from the gene of a maturation-specific monocot plant storage protein, wherein the promoter comprises SEQ ID NO.:8,

(ii) a first DNA sequence, operably linked to the promoter, encoding a signal sequence, and

(iii) a second DNA sequence, linked in translation frame with the first DNA sequence, encoding HSA, wherein the first DNA sequence and the second DNA sequence together encode a fusion protein comprising an N-terminal signal sequence and the HSA;

(b) growing a monocot plant from the transformed monocot plant cell for a time sufficient to produce seeds containing the HSA; and

(c) harvesting the seeds from the plant,

wherein the HSA constitutes at least about 10% of the total soluble protein in the harvested seeds.

2. The method of claim 1 , further comprising purifying the HSA from the harvested seeds.

Assignments (3)
CHANGE OF NAME Recorded Oct 30, 2023
From: VENTRIA BIOSCIENCE INC.
To: INVITRIA, INC.
Reel/Frame 065394/0517 →
MERGER Recorded Feb 28, 2014
From: VENTRIA BIOSCIENCE
To: VENTRIA BIOSCIENCE INC.
Reel/Frame 032325/0620 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2003
From: HUANG, NING; RODRIQUEZ, RAYMOND L.; HAGIE, FRANK E.; STALKER, DAVID M.
To: VENTRIA BIOSCIENCE
Reel/Frame 014341/0291 →
Continuity (6)
Continuation In Part 1007738100 · Feb 14, 2002
Continuation In Part 0984723200 · May 2, 2001
Provisional Application 6026919900 · Feb 14, 2001
Provisional Application 6026692900 · Feb 6, 2001
Provisional Application 6020118200 · May 2, 2000
Related Publication 20030221223A1 · Nov 27, 2003